// App-Quantinova.ai

: Efficacy and safety of abiraterone acetate plus prednisone and androgen deprivation therapy +/- docetaxel in older patients (≥70 years), with de novo metastatic-castration sensitive prostate cancer, compared to younger patients (<70 years): The PEACE-1 trial.

Researchers

Presenter

  • Loic Mourey

Principal Investigators

  • Guilhem Roubaud

  • Raymond S. McDermott

  • Stephane Supiot

  • Bertrand F. Tombal

  • Aude Flechon

  • Dominik R. Berthold

  • Philippe Ronchin

  • Gabriel Kacso

  • Jean Francois Berdah

  • Fabio Calabro

  • Gwenaelle Gravis

  • Samuel Palumbo

  • Thierry Gil

  • Brigitte Vie

  • Hélène Ribault

  • Karim Fizazi

  • Stéphanie Foulon

  • Joan Carles

Medical Centers

  • Cliniques Universitaires Saint-Luc, UCL, Brussels, MN, Belgium

  • Institut de Cancerologie de l'Ouestsite Rene Gauducheau, Saint Herblain, France

  • Centre Armoricain Radiothérapie Imagerie Oncologie, Plérin, France

  • Vall d'Hebron University Hospital, Barcelona, Spain

  • Azuréen Center of Oncology, Mougins, France

  • Pôle Hospitalier Jolimont, La Louvière, Belgium

  • St Vincent's University Hospital, Dublin, Ireland

  • Institut Paoli-Calmettes, Marseille, France

  • Institut Universitaire du Cancer de Toulouse, Toulouse, France

  • Gustave Roussy Cancer Campus, Villejuif, France

  • Institute Jules Bordet, Brussels, Belgium

  • Unicancer, Paris, France

  • Iuliu Hatieganu University, Cluj-Napoca, Romania

  • Cancérologie Médicale, Centre Léon-Bérard, Lyon Cedex, France

  • Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

  • Clinique Sainte Marguerite, Hyeres, France

  • Institut Bergonie, Bordeaux, France

  • Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy

  • Centre Leon Berard, Lyon, France

Locations

  • Belgium

  • Italy

  • France

  • Spain

  • Ireland

  • Switzerland

  • Romania

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • N/A

Drug/Treatment

  • CB-7598

  • Prednisone

  • Docetaxel

  • Androgen Tear

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • NCT01957436

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved